← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Executive Chair Philip Astley-Sparke sold $493K of Replimune Group, Inc.

Sold$493,290
$17.01Price
29,000Shares
−2%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Wed, Nov 6. Filed Fri, Nov 8, 9:16 PM ET, after the close. Not investment advice.